A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer

NCT01746043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Armodafinil
OTHER: Placebo
DRUG: Minocycline
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]